Tenderwize
Retour à la recherche

Accord de rabais non exclusif pour le naloxégol

AOK Niedersachsen. Die Gesundheitskasse.·Hannover, Germany·Deadline Jun 27, 2027 · 218 days left·Open·Supplies·Framework
Titre original de l'avis

Germany – Pharmaceutical products – Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Naloxegol (ATC-Code: A06AH03).

54/100

Score d'opportunité

Needs reviewMedium complexity
SuppliesFrameworkOpen
Pourquoi ce score ?

Opportunité

54 / 100

Complexité

61 / 100

Facteurs de risque

No estimated value, purchase volume, demand forecast, or guaranteed spend is provided.

Open-house contracts may end automatically when exclusive rebate contracts enter into force, potentially before 31 Augu...

No procurement documents available

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Niedersachsen. Die Gesundheitskasse.
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Jun 27, 2027

Aperçu

Moderate opportunity

Faits clés

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Aug 2027
  • Supply of medicinal products containing the active substance Naloxegol, ATC code A06AH03.
  • Conclusion of non-exclusive rebate agreements under Section 130a(8) SGB V.
Afficher le résumé complet

Open-house, non-exclusive rebate agreement for medicinal products containing Naloxegol (ATC A06AH03) with AOK Niedersachsen in Germany. Eligible pharmaceutical companies may join on uniform, non-negotiable terms during the maximum 24-month period. The agreement may be replaced by exclusive rebate contracts and may end automatically when those contracts enter into force. No contract value is provided, procurement documents are not included, and electronic submission is not permitted.

Risques

No estimated value, purchase volume, demand forecast, or guaranteed spend is provided.

Open-house contracts may end automatically when exclusive rebate contracts enter into force, potentially before 31 Augu...

No procurement documents available

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Participation is limited to pharmaceutical companies within the meaning of Section 4(18) AMG, or a consortium of such companies, in relation to the medicines offered.
  • The pharmaceutical company must be permitted to place the relevant medicinal products on the market under Section 9(2) AMG.
  • Local representatives may participate only if they themselves qualify as pharmaceutical companies for the relevant medicinal products.

Critères d'attribution

Lot 1

Price is identified as the award criterion, but no description or weighting is provided.

Acheteur

Localisation

Hannover, DEU

Identifiant

AOK- Niedersachsen. Die Gesundheitskasse

Activité

Health

Lots (1)

LOT-0000

Naloxegol non-exclusive rebate agreement

Non-exclusive rebate agreement for medicinal products containing Naloxegol (ATC A06AH03), offered to all interested eligible pharmaceutical companies under an open-house model. Contracts may be concluded from 1 September 2025 through the maximum term ending 31 August 2027, subject to the stated joining deadlines and possible earlier termination following exclusive contracts.

SuppliesFrameworkEU fundedElectronic submission

Localisation

DE929, Germany

Durée

Aug 2025 - Aug 2027

Catégorie

Pharmaceutical products

Critères d'attribution

Price

Date limite

Deadline Jun 27, 2027

Détails de la procédure

Date de publication
07 Jul 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
442672-2025

Appels d'offres similaires

Cookies & Privacy

With your consent, we use Google Analytics, Microsoft Clarity (session recordings) and Google Ads cookies to understand how Tenderwize is used and to measure our advertising. You can change your choice at any time via “Cookie Settings” in the footer. Cookie Policy · Privacy Policy